Laura A. Palomares
Laura A. Palomares is a Biochemical Engineer from the Monterrey Institute of Technology, Mexico. She has a doctoral degree from the National Autonomous University of Mexico (UNAM) and pursued postdoctoral training at Cornell University. She is the Director of the Biotechnology Institute of UNAM, where she is also a Professor, Principal Investigator, and Group Leader. She is vice chair of the Scientific Advisory Committee and interim chair of the Portfolio Strategy and Management Board of CEPI, a scientific expert for COFEPRIS (Mexican regulatory agency), and a founding expert of the Mexican Pharmacopoeia, Biotechnological drugs section. Her research focuses on vaccine development, process development for vaccine production, and vaccine and protein characterization. Palomares collaborated with Protein Sciences on the development of Flublok, the first licensed recombinant influenza vaccine, and participated in the technology transfer of Flublok to Mexico and its licensure in the country. Her work has been recognized with the most prestigious awards for scientists in Mexico.
Diamond Partners
